Published Oktober 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. The event will bring together leading experts from industry and academia to discuss the latest technological advances, innovations, challenges and opportunities in the rapidly evolving field of antibody-drug conjugates (ADCs).

Organised by the Royal Society of Chemistry Biological and Medicinal Chemistry Sector (RSC BMCS), the conference will explore the growing impact of ADCs and other targeted therapeutic modalities, highlighting recent clinical successes and the next generation of technologies shaping the future of drug discovery and development. The programme features presentations from renowned researchers and organisations at the forefront of ADC design, bioconjugation, payload development and therapeutic innovation.

Representing HGF at the event, Dr Thomas Lonsdale is a senior patent attorney with extensive expertise in patent drafting, prosecution, freedom-to-operate (FTO) analysis and opposition proceedings. He advises a broad range of clients across the chemistry, biochemistry, pharmaceutical and materials sectors, helping innovative businesses protect and maximise the value of their intellectual property.

Tom has particular experience working at the interface of chemistry and life sciences, with a strong interest in pharmaceutical innovation and emerging technologies. He holds a First-Class Master’s degree in Chemistry and a PhD in Inorganic Chemistry from the University of Oxford, bringing a deep technical understanding to complex innovations in the life sciences sector.

The ADC landscape continues to develop at pace, creating exciting opportunities for innovators while also presenting increasingly complex intellectual property considerations. Events such as BMCS Antibody–Drug Conjugates 2026 provide an invaluable forum for sharing scientific insights, exploring new technologies and discussing the commercialisation and protection of breakthrough therapies.

If you are attending the event and would like to discuss intellectual property strategies for antibody-drug conjugates, bioconjugates, pharmaceuticals or related technologies, Tom would be delighted to connect.

Aktuelle Neuigkeiten

Event - 12. November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Veranstaltungsdetails

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Weiterlesen
Event - 28. Oktober 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Veranstaltungsdetails

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Weiterlesen
Event - 28. Oktober 2026

HGF nimmt an der KINPA-Konferenz 2026 teil

HGF freut sich auf die Teilnahme an der KINPA-Konferenz 2026, die am 28. Oktober in Seoul, Südkorea, stattfindet. Als Koreas größte Veranstaltung zum Thema geistiges Eigentum bringt die Konferenz mehr …

Veranstaltungsdetails
Event - 17. bis 19. November 2026

HGF nimmt an der IPBC Asia 2026 teil

HGF freut sich bekannt zu geben, dass Partnerin Dr. Jennifer Uno an der IPBC Asia 2026 teilnehmen wird, die vom 17. bis 19. November 2026 in Tokio, Japan, stattfindet. Als …

Veranstaltungsdetails

HGF im Chambers and Partners UK Guide 2027 ausgezeichnet

HGF freut sich, erneut im Chambers and Partners UK Guide 2027 ausgezeichnet worden zu sein. Sowohl die Kanzlei als auch einzelne Berufsträger haben in mehreren Regionen hervorragende Platzierungen erzielt. Der …

Weiterlesen
Event - 4. November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Veranstaltungsdetails